Nature Communications (Oct 2020)

Piperacillin/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated amplification of bla TEM-1B

  • Alasdair T. M. Hubbard,
  • Jenifer Mason,
  • Paul Roberts,
  • Christopher M. Parry,
  • Caroline Corless,
  • Jon van Aartsen,
  • Alex Howard,
  • Issra Bulgasim,
  • Alice J. Fraser,
  • Emily R. Adams,
  • Adam P. Roberts,
  • Thomas Edwards

DOI
https://doi.org/10.1038/s41467-020-18668-2
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 9

Abstract

Read online

An E. coli and K. pneumoniae phenotype resistant to piperacillin/tazobactam has recently emerged. Here, the authors show that hyperproduction of the β-lactamase driving this resistance occurs due to excision and reinsertion of a translocatable unit containing bla TEM-1B, creating a tandem array.